Charles Schwab
ARAV

Charles Schwab’s Aravive, Inc. Common Stock ARAV Stock Holding History

Charles Schwab’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-27,004
Closed -$35.6K – 3600
2022
Q4 		$35.6K Buy
+27,004
New +$34.5K ﹤0.01% 3427
2021
Q2 		– Sell
-27,738
Closed -$183K – 3564
2021
Q1 		$183K Hold
27,738
– – ﹤0.01% 3327
2020
Q4 		$157K Hold
27,738
– – ﹤0.01% 3283
2020
Q3 		$131K Hold
27,738
– – ﹤0.01% 3233
2020
Q2 		$323K Buy
+27,738
New +$329K ﹤0.01% 3008
2018
Q2 		– Sell
-21,564
Closed -$214K – 3158
2018
Q1 		$214K Buy
21,564
+13,141
+156% +$148K ﹤0.01% 2971
2017
Q4 		$112K Sell
8,423
-8,213
-49% -$106K ﹤0.01% 3026
2017
Q3 		$245K Sell
16,636
-1,599
-9% -$161K ﹤0.01% 2948
2017
Q2 		$1.91M Buy
18,235
+105
+0.6% +$11.3K ﹤0.01% 2237
2017
Q1 		$2.32M Buy
18,130
+940
+5% +$99.1K ﹤0.01% 2157
2016
Q4 		$1.54M Buy
17,190
+5,181
+43% +$393K ﹤0.01% 2285
2016
Q3 		$883K Buy
12,009
+455
+4% +$32.9K ﹤0.01% 2434
2016
Q2 		$767K Buy
11,554
+2,073
+22% +$118K ﹤0.01% 2436
2016
Q1 		$457K Buy
9,481
+170
+2% +$9.02K ﹤0.01% 2613
2015
Q4 		$693K Buy
9,311
+217
+2% +$14.5K ﹤0.01% 2512
2015
Q3 		$630K Buy
9,094
+570
+7% +$53.5K ﹤0.01% 2537
2015
Q2 		$779K Buy
8,524
+3,835
+82% +$389K ﹤0.01% 2522
2015
Q1 		$517K Buy
4,689
+2,024
+76% +$237K ﹤0.01% 2618
2014
Q4 		$360K Buy
2,665
+61
+2% +$7.13K ﹤0.01% 2768
2014
Q3 		$297K Buy
2,604
+51
+2% +$6.76K ﹤0.01% 2802
2014
Q2 		$430K Buy
+2,553
New +$441K ﹤0.01% 2691

Other funds holding ARAV

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Charles Schwab's ARAV Position: Q1 2023 in Review

Charles Schwab sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2023, closing a stake of 27,004 shares — an estimated $35.6K sold.

Charles Schwab first reported a position in ARAV in Q2 2014 and held it in 21 quarters. The position peaked at $2.32M in Q1 2017. 36 funds tracked by Wall St. Rank hold ARAV as of Q1 2023.

  • Charles Schwab reported no remaining Aravive, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Charles Schwab sold 27,004 Aravive, Inc. Common Stock shares in Q1 2023, an estimated $35.6K.
  • Charles Schwab first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 21 quarters.
  • Charles Schwab's Aravive, Inc. Common Stock position peaked at $2.32M in Q1 2017.
  • 36 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2023.

Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.